| RFNCX | VSMPX | RFNCX / VSMPX | |
| Total Expense Ratio | 0.93 | 0.02 | 4,650% |
| Annual Report Gross Expense Ratio | 0.93 | 0.02 | 4,650% |
| Fund Existence | 24 years | 11 years | - |
| Gain YTD | 12.893 | 12.876 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 178B | 2.29T | 8% |
| Annual Yield % from dividends | 0.31 | 1.07 | 29% |
| Returns for 1 year | 16.89 | 21.03 | 80% |
| Returns for 3 years | 56.52 | 74.33 | 76% |
| Returns for 5 years | 37.83 | 66.62 | 57% |
| Returns for 10 years | 96.75 | 238.83 | 41% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HLMOX | 9.72 | 0.10 | +1.04% |
| Harding Loevner Frontier Emerg Mkts Inv | |||
| GGHYX | 44.29 | 0.43 | +0.98% |
| Invesco Health Care Y | |||
| PRJDX | 37.71 | 0.17 | +0.45% |
| PGIM Jennison Global Opportunities R4 | |||
| TRSAX | 104.37 | 0.38 | +0.37% |
| T. Rowe Price Growth Stock Adv | |||
| IUAIX | 34.44 | N/A | N/A |
| VY® Invesco Equity and Income I | |||